Target intelligence / Profile preview

Olfactory receptor family 2 subfamily L member 2 (OR2L2)

Target
OR2L2
Molecular classification
G protein-coupled receptor, Receptor, Olfactory receptor
01

Overview

Olfactory receptor family 2 subfamily L member 2 (OR2L2) is a G protein-coupled receptor expressed in the olfactory epithelium, responsible for detecting odorant molecules in the nose and initiating neuronal signaling that leads to the perception of smell. Like other olfactory receptors, OR2L2 is a member of the large class A GPCR family, encoded by a single coding exon, and possesses a characteristic 7-transmembrane domain structure shared with other neurotransmitter and hormone receptors. OR2L2 is involved in the recognition and G protein-mediated transduction of odorant signals but is not a validated therapeutic or drug target. There is no evidence for direct involvement in common human diseases, and there are no known drug interactions or biomarker uses for this specific receptor. Note: Some aliases correspond to predicted genes or pseudogenes, which is common among olfactory receptor nomenclature; OR2L2 itself is considered a protein-coding gene. Other similar names may denote closely related, but distinct, family members or genomic loci.

Other names
Olfactory receptor 2L2OR2L12OR2L4PHTPCRH07HSHTPCRH07olfactory receptor 2L12olfactory receptor 2L4Olfactory receptor OR1-48 pseudogeneolfactory receptor, family 2, subfamily L, member 12olfactory receptor, family 2, subfamily L, member 4 pseudogeneOR1-48
02

Mechanism of action

N/A (not a therapeutic drug target; mechanism is endogenous odorant ligand binding and G-protein activation)

03

Biological functions

Signal transductionOdorant recognitionG protein-mediated transduction of odorant signals
04

Disease associations

Other (no strong data linking to major disease categories; rare mentions associated with "plexopathy" but not considered a validated disease target)
05

Safety considerations

None documented. Olfactory receptors as a class are not associated with significant therapeutic safety challenges because they are not therapeutic targets
06

Interacting drugs

None known (no drugs currently known to specifically target OR2L2; olfactory receptors are generally not drug targets)
07

Biomarkers

None known

Beyond the preview

Go deeper on Olfactory receptor family 2 subfamily L member 2 (OR2L2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 2 subfamily L member 2 (OR2L2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call